Inspection Record

All Clean Natural Ltd. — Health Canada Inspection Findings

Health CanadaInspected 2022-06-01 14 findingsOther quality systemEquipment and facilityCleaning validationTraining and personnelMaterial and supplier controlStability and storageComputer system validationDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The written specifications were inadequate.

2Equipment and facility

Changes to production processes, systems, equipment, materials, and/or suppliers were not validated before they were implemented.

3Cleaning validation

The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

4Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

5Other quality system

The company's oversight of the contracted party was inadequate.

6Training and personnel

The ongoing training of personnel was inadequate.

7Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

8Material and supplier control

The company did not determine the stability of the drug before it was marketed or before significant changes were made to the drug formulations, fabrication procedures, or packaging materials.

9Material and supplier control

The control of quarantine areas was inadequate. The segregation, rotation of stock, and/or the transportation of raw materials, packaging materials, intermediates, bulk drugs, and/or finished products was inadequate.

10Stability and storage

The temperature and/or humidity control was inadequate.

11Other quality system

The master production documents were inadequate.

12Other quality system

Complete testing was not performed according to the requirements.

13Computer system validation

The computerized system used to manage product inventory and distribution records to support recalls was not validated. The distribution records did not allow each drug to be traced individually.

14Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-06-01. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

All Clean Natural Ltd. company profile — full history Health Canada documents, 2022 Go to Findings search